Preclinical Safety Evaluation: Acute and Repeated-Dose Toxicity of a New Intranasal Recombinant Vector Vaccine TB/FLU-04L Against Tuberculosis
Note: employees of the Institute are marked with an asterisk (*) in the list of authors.
Web of Science ,
Scopus
Authors
Stosman K., Sivak K., Aleksandrov A., Buzitskaya Z., Rassokha T., Stukova M.
Publication type
Journal article
Indexed in
Info:
Published in
Drug Research
Year of publication
2022
Volume
72
Number
4
Pages
215-219
